News-Papers
Testimonial
Video Gallery
Search
Follow us...
Latest
- Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A 13C Stable Isotope-Resolved Metabolomic Study
- Inhibition of Moloney murine lymphoma and sarcoma growth in vivo by dietary retinoids
- Long-acting somatostatin analogues in the treatment of unresectable/metastatic neuroendocrine tumors
- 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling
- Expressions of Somatostatin Receptor Subtypes (SSTR-1, 2, 3, 4 and 5) in Neuroblastic Tumors; Special Reference to Clinicopathological Correlations with International Neuroblastoma Pathology Classification and Outcomes
- Characterization of somatostatin receptors on human neuroblastoma tumors
- Somatostatin in neuroblastoma and ganglioneuroma
- Octreotide enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro
- Inhibition of Human Epithelial Ovarian Cancer Cell Growth in vitro by Somatostatin Analog RC-160
- Melatonin Synergizes the Chemotherapeutic Effect of Cisplatin in Ovarian Cancer Cells Independently of MT1 Melatonin Receptors
- Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer
- Pretreatment with melatonin protects against cyclophosphamide-induced oxidative stress and renal damage in mice
Most Read
- All-trans-retinoic acid and cancer
- The Di Bella Method (DBM)
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Biography
- About melatonin - 1996
- Bibliography
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Somatostatin in oncology, the overlooked evidences
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Vademecum
- How effective is chemo therapy?
- Frequently Asked Questions